Atomera (NASDAQ: ATOM) details 2025 loss, cash and Q4 results

Rhea-AI Filing Summary

Atomera Incorporated reported fourth-quarter and full-year 2025 results, showing a company still in investment mode with modest revenue and continuing losses. In Q4 2025, Atomera posted a net loss of $4.4 million, or $0.14 per share, an improvement from a $5.6 million loss in Q3 2025 and $4.7 million a year earlier, helped by lower operating expenses and higher interest income.

For fiscal 2025, revenue was $65,000, down from $135,000 in 2024, while net loss widened to $20.2 million, or $0.65 per share, compared with a $18.4 million loss, or $0.68 per share, in 2024. Adjusted EBITDA loss increased slightly to $16.1 million from $15.4 million, reflecting sustained spending on research and operations. Atomera ended December 31, 2025 with $19.2 million in cash, cash equivalents and short-term investments and 32.4 million shares outstanding, providing liquidity to support ongoing development despite the lack of significant revenue.

Insights

Equity research analyst

Atomera’s 2025 results show shrinking revenue, higher annual losses and a declining cash balance despite quarterly loss improvement.

Atomera generated minimal revenue of $65,000 in 2025, down from $135,000 in 2024, underscoring that its technology is not yet producing meaningful commercial sales. Full-year net loss widened to $20.2 million, and adjusted EBITDA loss increased to $16.1 million, indicating continued heavy investment relative to revenue.

On the positive side, Q4 2025 net loss narrowed to $4.4 million from $5.6 million in Q3 2025, and adjusted EBITDA loss also improved, helped by lower operating expenses and solid interest income. However, cash, cash equivalents and short-term investments fell from $26.8 million at December 31, 2024 to $19.2 million at December 31, 2025, while operating expenses reached $20.9 million for the year.

This combination of limited revenue, sizeable ongoing losses and a declining cash balance suggests Atomera remains dependent on external capital or future revenue growth to fund operations. Subsequent filings will indicate how management balances R&D spending, cash preservation and any potential revenue ramp following the fiscal 2025 period.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 02/23/2026 - 06:05 AM Learn about SEC filing dates

false 0001420520 0001420520 2026-02-23 2026-02-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 23, 2026

ATOMERA INCORPORATED

(Exact Name of Registrant as Specified in Its Charter)

Delaware	001-37850	30-0509586
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

750 University Avenue, Suite 280

Los Gatos, California 95032

(Address of principal executive offices)

(408) 442-5248

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock: Par value $0.001		ATOM		Nasdaq Capital Markets

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Information.

We recently completed our 2025 fiscal year. Attached hereto as Exhibit 99.1 is a summary of our results of operations and financial condition as of and for the three and 12 months ended December 31, 2025. The information set forth in Exhibit 99.1 to this Current Report on Form 8-K is hereby incorporated by reference into this Item 8.01.  

Item 9.01 Financial Statements and Exhibits

(d) Exhibits Method Filing

Filed Electronically herewith 

99.1	Summary Financial Information	Filed Electronically herewith
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)	Filed Electronically herewith

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	ATOMERA INCORPORATED
Dated: February 23, 2026	/s/ Francis B. Laurencio
	Francis B. Laurencio, Chief Financial Officer

3

Exhibit 99.1

Financial Results

Atomera Incorporated (the “Company”) incurred a net loss of ($4.4) million, or ($0.14) per basic and diluted share in the fourth quarter of 2025, compared to a net loss of ($5.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2025, and a net loss of ($4.7) million, or ($0.16) per basic and diluted share, for the fourth quarter of 2024. Adjusted EBITDA (a non-GAAP financial measure) in the fourth quarter of 2025 was a loss of ($3.3) million compared to an adjusted EBITDA loss of ($4.4) million in the third quarter of 2025 and ($3.9) million in the fourth quarter of 2024.

For fiscal year 2025, revenue was $65,000, compared with $135,000 in fiscal 2024. Net loss was ($20.2) million, or ($0.65) per basic and diluted share for fiscal 2025, compared to ($18.4) million, or ($0.68) per basic and diluted share in fiscal 2024. Adjusted EBITDA for fiscal 2025 was a loss of ($16.1) million compared to an adjusted EBITDA loss of ($15.4) million in fiscal 2024.

The Company had $19.2 million in cash, cash equivalents and short-term investments as of December 31, 2025, compared to $26.8 million as of December 31, 2024.

The total number of shares outstanding was 32.4 million as of December 31, 2025.

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

-- Financial Tables Follow --

1

Atomera Incorporated

Balance Sheets

(in thousands, except per share data)

		December 31,				December 31,
		2025				2024
		(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents		$	19,210			$	25,778
Short-term investments			–				995
Accounts receivable			–				6
Interest receivable			54				73
Prepaid expenses and other current assets			338				240
Total current assets			19,602				27,092
Property and equipment, net			60				59
Long-term prepaid maintenance and supplies			–				91
Security deposit			14				14
Operating lease right-of-use asset			884				280
Financing lease right-of-use-asset			533				1,588
Total assets		$	21,093			$	29,124
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	608			$	492
Accrued expenses			168				239
Accrued payroll related expenses			650				1,328
Current operating lease liability			147				260
Current financing lease liability			420				1,253
Deferred revenue			7				4
Total current liabilities			2,000				3,576
Long-term operating lease liability			712				22
Long-term financing lease liability			–				449
Total liabilities			2,712				4,047
Commitments and contingencies			–				–
Stockholders’ equity:
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding at December 31, 2025 and December 31, 2024			–				–
Common stock: $0.001 par value, authorized 47,500 shares; 32,354 and 30,540 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively;			32				31
Additional paid-in capital			260,043				246,565
Other comprehensive income			–				1
Accumulated deficit			(241,694	)			(221,520	)
Total stockholders’ equity			18,381				25,077
Total liabilities and stockholders’ equity		$	21,093			$	29,124

2

Atomera Incorporated

Statements of Operations

(in thousands, except per share data)

		Three Months Ended												Year Ended
		December 31,				September 30,				December 31,				December 31,
		2025				2025				2024				2025				2024
		(Unaudited)				(Unaudited)				(Unaudited)				(Unaudited)
Revenue		$	50			$	11			$	23			$	65			$	135
Cost of revenue			(131	)			(128	)			(13	)			(321	)			(123	)
Gross margin			(81	)			(117	)			10				(256	)			12
Operating expenses
Research and development			2,740				3,304				2,823				12,303				11,029
General and administrative			1,505				2,165				1,811				7,806				7,266
Selling and marketing			286				207				248				758				1,053
Total operating expenses			4,531				5,676				4,882				20,867				19,348
Loss from operations			(4,612	)			(5,793	)			(4,872	)			(21,123	)			(19,336	)
Other income (expense)
Interest income			195				232				213				931				779
Accretion income			–				–				26				6				178
Other income, net			1				–				1				72				73
Interest expense			(9	)			(12	)			(25	)			(60	)			(129	)
Total other income (expense), net			187				220				215				949				901
Net loss			(4,425	)		$	(5,573	)			(4,657	)			(20,174	)			(18,435	)
Net loss per common share, basic and diluted			(0.14	)		$	(0.17	)			(0.16	)			(0.65	)			(0.68	)
Weighted average number of common shares outstanding, basic and diluted			31,590				31,128				28,934				30,844				27,217

3

Atomera Incorporated

Reconciliation to Non-GAAP Adjusted EBITDA

(Unaudited)

		Three Months Ended																Year Ended
		December 31,				September 30,								December 31,				December 31,
		2025				2025								2024				2025				2024
Net loss (GAAP)			(4,425	)			$				(5,573	)			(4,657	)			(20,174	)			(18,435	)
Depreciation and amortization			13								11				12				48				54
Stock-based compensation			1,334								1,342				949				4,963				3,867
Interest income			(195	)							(232	)			(213	)			(931	)			(779	)
Accretion income			–								–				(26	)			(6	)			(178	)
Other income, net			(1	)							–				(1	)			(72	)			(73	)
Interest expense			9								12				25				60				129
Net loss non-GAAP Adjusted EBITDA			(3,265	)			$				(4,440	)			(3,911	)			(16,112	)			(15,415	)

4

FAQ

How did Atomera (ATOM) perform financially in Q4 2025?

Atomera reported a Q4 2025 net loss of $4.4 million, or $0.14 per share, improving from a $5.6 million loss in Q3 2025. Adjusted EBITDA loss also narrowed to $3.3 million, reflecting reduced operating expenses and steady interest income.

What were Atomera (ATOM) full-year 2025 revenue and net loss?

For 2025, Atomera generated $65,000 in revenue and recorded a net loss of $20.2 million, or $0.65 per share. In 2024, revenue was $135,000 and net loss was $18.4 million, or $0.68 per share.

How did Atomera’s adjusted EBITDA change in 2025 versus 2024?

Atomera’s adjusted EBITDA loss was $16.1 million in 2025, slightly worse than the $15.4 million loss in 2024. The company continues to invest heavily in research, development and operations despite generating relatively small levels of revenue.

What is Atomera’s (ATOM) cash position at the end of 2025?

Atomera ended December 31, 2025 with $19.2 million in cash, cash equivalents and short-term investments, down from $26.8 million a year earlier. This decline reflects funding of operating losses and ongoing development activities throughout fiscal 2025.

How many Atomera (ATOM) shares were outstanding at December 31, 2025?

Atomera had 32.4 million common shares outstanding as of December 31, 2025, up from 30.5 million shares a year earlier. The increase reflects equity issuance, which supports funding needs but also modestly dilutes existing shareholders.

How did Atomera’s operating expenses trend in fiscal 2025?

Total operating expenses were $20.9 million in 2025, compared with $19.3 million in 2024. Research and development rose to $12.3 million, while general and administrative costs reached $7.8 million, highlighting continued investment in technology and corporate infrastructure.

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 FINANCIAL RESULTS 95.4 KB

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB